Evidence for the persistence of monoclonal expansions of CD8+ T cells following primary simian immunodeficiency virus infection. by Wilson, J, Cranage, M, Cook, N, Leech, S, Mcmichael, A, Callan, M

Replication-deficient recombinant adenoviruses expressing the human immunodeficiency virus Env antigen can induce both humoral and CTL immune responses in mice. by Bruce, C, Akrigg, A, Sharpe, SA, Hanke, T, Wilkinson, G, Cranage, M

Mucosal immunization with PLGA-microencapsulated DNA primes a SIV-specific CTL response revealed by boosting with cognate recombinant modified vaccinia virus Ankara. by Sharpe, S, Hanke, T, Tinsley-Bown, A, Dennis, M, Dowall, S, McMichael, A, Cranage, M

Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-exis... by Sharpe, S, Polyanskaya, N, Dennis, M, Sutter, G, Hanke, T, Erfle, V, Hirsch, V, Cranage, M

Vaginal Delivery of a Recombinant HIV-1 Clade-C Trimeric gp140 within Novel Rheologically Structured Vehicles Induces Specific Immune Responses by Curran, R, Donnelly, L, Morrow, R, Andrews, G, Malcolm, K, Woolfson, D, Wegmann, F, Sattentau, Q, Cranage, M, Fraser, C

Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost va... by Hanke, T, Samuel, R, Blanchard, T, Neumann, VC, Allen, T, Boyson, J, Sharpe, SA, Cook, N, Smith, G, Watkins, D, Cranage, M, Mcmichael, A

P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV by Berkhout B, Klaver B, Kleibeuker W, Das AT, Page M, Robinson M, Quartey-Papafio R, Stebbings R, Manoussaka MS, Almond N, Cranage M

P11-06. Intravaginal administration of HIV-1ZM96 gp140 augments systemic and mucosal antibody responses following systemic priming with adjuvanted protein by Almond N, Armanasco N, Fletcher P, DaCosta K, Mahmoud AN, Page M, Elsley W, McKay P, Cope A, Fraser C, Cranage M, Shattock R

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine by Giemza E, Cai C, Cope A, Woodrow M, Wiggins R, Fraser C, Cole T, Jeffs S, Lacey CJ, Lewis DJ, Mahmhoud A, Katinger D, Cranage M, Shattock R

Assessment of mucosal immunity to HIV-1. by Jespers, V, Harandi, A, Hinkula, J, Medaglini, D, Le Grand, R, Stahl-Hennig, C, Bogers, W, El Habib, R, Wegmann, F, Fraser, C, Cranage, M, Shattock, R, Spetz, A

P03-08. Protection against SIVmac239 challenge in a rhesus macaque model conferred by a doxycycline dependent attenuated SIVmac239 by Cranage M, Stebbings R, Manoussaka M, Li B, Klaver B, Kleibeuker W, Das A, Tudor H, Elsley W, Quartey-Papafio R, Robinson M, Berry N, Page M, Berkhout B, Almond N

Novel vaccine and gene therapy approaches against HIV-AIDS by Manoussaka M, Li B, Elsley W, Quartey-Papafio R, Robinson M, Page M, Tudor H, Berry N, Legrand N, Centlivre M, ter Brake O, Liu YP, von Eije K, Klaver B, Kleibeuker W, Das A, Stebbings R, Cranage M, Almond N, Berkhout B